Scientists at the University of Calgary have developed a neuro chip that could one day be used in the treatment of Parkinson’s, epilepsy and other neurological diseases.
The “bionic hybrid neuro chip” is able to record activity in animal brain cells for long periods of time, and in much greater detail than other existing technologies, according to lead researcher Pierre Wijdenes.
That, he says, creates the opportunity to develop highly personalized medication in hard-to-treat epilepsy cases, for example.
“If you start to have seizures and you go your doctor … the doctor will try different drug combinations on you. That will work for 50 to 60 per cent of patients, but for the other ones, this medication may not work,” Wijdenes told CBC News.
In that case, one of the only options left for patients is surgery, in which the neurosurgeon would remove the part of the brain that is responsible for the seizures, he added.
“We can take a sample of this tissue and do some drug testing … right next to the O.R., and be able to test different drug compounds [and] find out the best medication that works [for this particular patient],” Wijdenes said.
“So we’re actually getting closer to personal medication in a sense.”
Wijdenes said the new chip is a “baby step” along the path to developing that kind of treatment, which could still be decades away.
Chip tricks brain cells into a relationship
The technological advancement was published in the journal Scientific Reports this month.
The chip works by mimicking the natural biological contact between brain cells, essentially tricking the brain cells into believing that they are connecting with other brain cells.
“We simulated what Mother Nature does in nature, and provided brain cells with an environment where they feel as if they are at home,” said study co-author Naweed Syed, of the university’s Cumming School of Medicine.
For now, the researchers are working on brain tissue from snails and mice.